Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: NEOG

Neogen Corporation

Healthcare | Medical - Diagnostics & Research

No licensed closing price on file for NEOG. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$-0.26

Neogen Corporation (NASDAQ: NEOG) is a diagnostics and research company. Figures from SEC EDGAR; updated 2026-11-02 23:21 UTC.

What Neogen Corporation does

Neogen Corporation develops, manufactures, and markets products and services dedicated to food and animal safety. The Food Safety segment provides diagnostic test kits and complementary products such as culture media to food and feed producers to prevent contamination, foodborne illnesses, and detect quality issues. The Animal Safety segment develops veterinary instruments, pharmaceuticals, vaccines, diagnostics, rodent control products, and genomics testing services for the worldwide animal market, marketed through veterinarians, retailers, and distributors.

Summarized from Neogen Corporation’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.

Key facts

Valuation
EPS (TTM)$-0.26
Debt/equity0.37

Revenue, margins & earnings

FY2022 Net income: $48MFY2022 Taxes & interest: $10MFY2022 Operating expenses: $184MFY2022 Cost of revenue: $284M$527MFY2022FY2023: net loss $23M on revenue $822M$822MFY2023FY2024: net loss $9M on revenue $924M$924MFY2024FY2025: net loss $1.09B on revenue $895M$895MFY2025FY2026: net loss $8M on revenue $870M$870MFY2026
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
  • Net loss year
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-10-30
  • 2026-10-30DirectorRestricted Stock UnitsOption exercise-1,776$21.7K
  • 2026-10-30VP, Animal HealthTax withholding-337$4.1K
  • 2026-10-30DirectorRestricted Stock UnitsOption exercise-1,776$21.7K
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Neogen Corporation do?

Neogen Corporation develops, manufactures, and markets products and services dedicated to food and animal safety.

When did NEOG last file with the SEC?

Neogen Corporation's most recent SEC filing on record is a 8-K filed 2026-04-20. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-11-02 23:21 UTC. This page is also available as JSON at /api/data?ticker=NEOG and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for NEOG and 5,000+ tickers.

Create a free account — keep NEOG
For your agent
GET /api/data?ticker=NEOG

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt